nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel combinatorial strategy using Seliciclib® and Belinostat® for eradication of non-small cell lung cancer via apoptosis induction and BID activation
|
Ong, Pei-Shi |
|
2016 |
381 |
1 |
p. 49-57 9 p. |
artikel |
2 |
A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis
|
Li, Ning |
|
2016 |
381 |
1 |
p. 14-22 9 p. |
artikel |
3 |
ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma
|
Xu, Shiqiong |
|
2016 |
381 |
1 |
p. 41-48 8 p. |
artikel |
4 |
ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis
|
Lu, Haiquan |
|
2016 |
381 |
1 |
p. 23-30 8 p. |
artikel |
5 |
BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatin
|
Marzec, Kamila A. |
|
2016 |
381 |
1 |
p. 149-155 7 p. |
artikel |
6 |
“Cell identity” crisis: Another call for immediate action
|
Elgui de Oliveira, Deilson |
|
2016 |
381 |
1 |
p. 122-123 2 p. |
artikel |
7 |
Circulating microRNAs in cancer: Hope or hype?
|
Singh, Rajbir |
|
2016 |
381 |
1 |
p. 113-121 9 p. |
artikel |
8 |
Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression
|
Yi, Canhui |
|
2016 |
381 |
1 |
p. 1-13 13 p. |
artikel |
9 |
Current progress in immunotherapy for pancreatic cancer
|
Foley, Kelly |
|
2016 |
381 |
1 |
p. 244-251 8 p. |
artikel |
10 |
Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells
|
Lin, Renyu |
|
2016 |
381 |
1 |
p. 165-175 11 p. |
artikel |
11 |
Dual targeting and enhanced cytotoxicity to HER2-overexpressing tumors by immunoapoptotin-armored mesenchymal stem cells
|
Cai, Yanhui |
|
2016 |
381 |
1 |
p. 104-112 9 p. |
artikel |
12 |
Editorial Board
|
|
|
2016 |
381 |
1 |
p. ii- 1 p. |
artikel |
13 |
Elevated Orai1 and STIM1 expressions upregulate MACC1 expression to promote tumor cell proliferation, metabolism, migration, and invasion in human gastric cancer
|
Xia, Jianling |
|
2016 |
381 |
1 |
p. 31-40 10 p. |
artikel |
14 |
Gap junction as an intercellular glue: Emerging roles in cancer EMT and metastasis
|
Mao, Xiao-Yuan |
|
2016 |
381 |
1 |
p. 133-137 5 p. |
artikel |
15 |
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
|
Roh, Jong-Lyel |
|
2016 |
381 |
1 |
p. 96-103 8 p. |
artikel |
16 |
Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma
|
Lin, Hsiao-Hui |
|
2016 |
381 |
1 |
p. 58-66 9 p. |
artikel |
17 |
Interleukin-10 attenuates tumour growth by inhibiting interleukin-6/signal transducer and activator of transcription 3 signalling in myeloid-derived suppressor cells
|
Lee, Bo-Ra |
|
2016 |
381 |
1 |
p. 156-164 9 p. |
artikel |
18 |
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib
|
Tilio, Martina |
|
2016 |
381 |
1 |
p. 76-84 9 p. |
artikel |
19 |
Key role of pancreatic stellate cells in pancreatic cancer
|
Pothula, Srinivasa P. |
|
2016 |
381 |
1 |
p. 194-200 7 p. |
artikel |
20 |
Macrophages and pancreatic ductal adenocarcinoma
|
Habtezion, Aida |
|
2016 |
381 |
1 |
p. 211-216 6 p. |
artikel |
21 |
Matrix control of pancreatic cancer: New insights into fibronectin signaling
|
Topalovski, Mary |
|
2016 |
381 |
1 |
p. 252-258 7 p. |
artikel |
22 |
Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically
|
Yuan, Xiangfei |
|
2016 |
381 |
1 |
p. 85-95 11 p. |
artikel |
23 |
Modifiable and non-modifiable risk factors for pancreatic cancer: A review
|
Midha, Shallu |
|
2016 |
381 |
1 |
p. 269-277 9 p. |
artikel |
24 |
Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma
|
Craven, Kelly E. |
|
2016 |
381 |
1 |
p. 201-210 10 p. |
artikel |
25 |
P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines
|
Gallo-Oller, Gabriel |
|
2016 |
381 |
1 |
p. 67-75 9 p. |
artikel |
26 |
Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer
|
Bauer, Christian |
|
2016 |
381 |
1 |
p. 259-268 10 p. |
artikel |
27 |
Reactive oxygen species-mediated synergistic and preferential induction of cell death and reduction of clonogenic resistance in breast cancer cells by combined cisplatin and FK228
|
Pluchino, Lenora Ann |
|
2016 |
381 |
1 |
p. 124-132 9 p. |
artikel |
28 |
RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A
|
Kong, Ye |
|
2016 |
381 |
1 |
p. 138-148 11 p. |
artikel |
29 |
Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors
|
Glinsky, Gennadi V. |
|
2016 |
381 |
1 |
p. 176-193 18 p. |
artikel |
30 |
The lymphatic system and pancreatic cancer
|
Fink, Darci M. |
|
2016 |
381 |
1 |
p. 217-236 20 p. |
artikel |
31 |
Toward stratification of patients with pancreatic cancer: Past lessons from traditional approaches and future applications with physical biomarkers
|
Koay, Eugene J. |
|
2016 |
381 |
1 |
p. 237-243 7 p. |
artikel |